I. Kmicikiewicz et al., THE EFFECT OF AROMATASE INHIBITOR ON BASAL AND TESTOSTERONE-SUPPLEMENTED ESTRADIOL SECRETION BY LEYDIG-CELLS IN-VITRO, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(2), 1997, pp. 113-118
The effect of increasing concentrations of aromatase inhibitor CGS 169
49 A on LH- and testosterone-supplemented estradiol secretion by Leydi
g cells was studied. Leydig cells were obtained from mice at different
ages from 15- to 140-day-old. They were either incubated for 6 hrs wi
th LH and/or testosterone (LH/testosterone-supplemented cultures), or
as the control cultures. Aromatase inhibitor was added for further 18h
. After 24-h incubation period estradiol secretion was radioimmunologi
cally examined. Leydig cell aromatase activity appeared to depend on t
he age of the donor mice, being higher in mature than in juvenile anim
als. Furthermore, the Leydig cells from 30-day-old mice seemed to reve
al such an increasing aromatase activity resulting in the higher level
of synthetized estradiol. Aromatase inhibitor influenced the Leydig c
ell functions in a dose-dependent manner (60-70-day-old mice), or inde
pendently of the dose used. This supports the hypothesis that Leydig c
ells from the testes of mature mice are the main site of an active aro
matase.